Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Veterinary Injectable Devices Market size was over USD 948.24 million in 2024 and is poised to exceed USD 1.85 billion by 2037, witnessing over 5.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of veterinary injectable devices is estimated at USD 1.03 billion.
The increasing number of pet owners globally is boosting the demand for veterinary injectable devices. Since pet owners are investing highly in the health of their pets.
Furthermore, new drug delivery systems that enhance the convenience, safety, and efficiency of veterinary injection devices are open to development. The increasing investment in R&D for veterinary products is significantly increasing the demand for new and innovated devices. These factors are bolstering the market growth of veterinary injectable devices.
Veterinary Injectable Devices Sector: Growth Drivers and Challenges
Growth Drivers
-
Growing Demand for Animal Healthcare – The focus on animal health and well-being has led to an increase in demand for animal care, which includes the use of injectable medicinal products. The increasing demand for veterinary injectable medicinal products is driving a more proactive attitude by pet owners and animal farmers to seek preventive and curative treatment options. With about 15% of the veterinary injectable devices market at the time, Zoetis had the greatest share in the animal healthcare industry. Boehringer Ingelheim, the second-placed business, had almost 10% of the industry.
-
Advancements in Technology - Significant progress in the development of device design, materials, and features has been made in the animal injection device market. Innovative injectables offering improved accuracy, convenience of use, and safety for both animals and users have been developed by manufacturers. These developments have improved the efficiency and effectiveness of animal health treatments.
- Increasing Prevalence of Zoonotic Diseases – Due to the possibility of spreading infections, an increase in pet ownership puts human health at risk. Zoonotic is an illness that can be passed on from animals to humans. The number of zoonotic diseases worldwide is therefore increasing rapidly. According to research by the WHO, zoonotic diseases cause millions of deaths and about a billion cases of illness each year.
Challenges
-
Stringent Regulatory Supplies – A strict regulatory regime governing the approval and marketing of injectable medicinal products and devices is applicable to the animal health industry. Compliance with these provisions may present challenges to manufacturers and limit market development, which can take a substantial amount of time and cost.
-
High Cost of Veterinary Care
- Injuries and Infections due to Needles
Veterinary Injectable Devices Market: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.3% |
|
Base Year Market Size (2024) |
USD 948.24 million |
|
Forecast Year Market Size (2037) |
USD 1.85 billion |
|
Regional Scope |
|
Veterinary Injectable Devices Segmentation
Usability (Disposable, Re-Usable)
Disposable segment is expected to account for remarkable veterinary injectable devices market share by 2037. The emphasis on a high level of security, reduced risk of infections, convenience, and time effectiveness for veterinarians, together with cost-effectiveness are factors that contribute to the increased demand for disposable devices in the animal health sector.
End-User (Veterinary Hospitals, Veterinary Clinics)
The veterinary clinics segment is expected to hold 55% share of the global veterinary injectable devices market during the forecast period.The demand for veterinary services is increasing owing to the growing popularity of pet ownership, shifting demographics, and the growing awareness of animal healthcare. A major provider of animal health services is the veterinary clinic.
Our in-depth analysis of the global veterinary injectable devices market includes the following segments:
|
Product |
|
|
Usability |
|
|
Materials |
|
|
End-User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportVeterinary Injectable Devices Industry - Regional Synopsis
North American Market Forecast
North America industry is anticipated to account for largest revenue share of 35% by 2037. North America is generating the highest revenue owing to the presence of better healthcare facilities. Future trends in the region have also been driven by an increase in spending on companion animals in the United States, which has led to growing market momentum for Veterinary Injectable Devices. Also, the growing adoption of pets in the region is propelling the market growth of veterinary injectable devices.
APAC Market Statistics
Asia Pacific veterinary injectable devices market is anticipated to hold the second largest share of 26.1% owing to the development of major poultry businesses, large numbers of animals on farms, and an increase in animal healthcare infrastructure. The risk of contracting the disease is higher in livestock and poultry than in companion animals, and the death of livestock and poultry will lead to financial losses. Government assistance for the protection of farm animals against diseases is used to vaccinate them, and it is expected that this will lead to a higher level of local sales of veterinary injectables.
Companies Dominating the Veterinary Injectable Devices Market
- Boehringer Ingelheim International GmbH
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- NuGen Medical Devices Inc
- NEOGEN Corporation
- Phibro Animal Health
- Zoetis Inc
Recent Developments
- NEOGEN Corporation announced that the company had acquired the companion animal health company, CAPInnoVet, Inc. The acquisition would help NEOGEN to expand its portfolio in pet medications to the veterinary market.
- Boehringer Ingelheim announced that its intramuscular needle-free device, FreVAX, can now be managed with the new version of FreVAX smartphone app.
Author Credits: Radhika Pawar
- Report ID: 871
- Published Date: Dec 20, 2024
- Report Format: PDF, PPT
